메뉴 건너뛰기




Volumn 247, Issue 12, 2015, Pages 1419-1426

Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma

Author keywords

[No Author keywords available]

Indexed keywords

BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; SULFONAMIDE; THIAZINE DERIVATIVE; THIOPHENE DERIVATIVE;

EID: 84951808183     PISSN: 00031488     EISSN: 1943569X     Source Type: Journal    
DOI: 10.2460/javma.247.12.1419     Document Type: Article
Times cited : (9)

References (34)
  • 2
    • 84899488124 scopus 로고    scopus 로고
    • Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: A multicenter retrospective study (2004-2012)
    • Dees DD, Fritz KJ, Maclaren NE, et al. Efficacy of prophylactic antiglaucoma and anti-inflammatory medications in canine primary angle-closure glaucoma: a multicenter retrospective study (2004-2012). Vet Ophthalmol 2014;17:195-200.
    • (2014) Vet Ophthalmol , vol.17 , pp. 195-200
    • Dees, D.D.1    Fritz, K.J.2    Maclaren, N.E.3
  • 3
    • 0038134974 scopus 로고    scopus 로고
    • Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: Effect on the quality of life of glaucoma patients with drug-related side effects
    • Nesher R, Ticho U. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects. Isr Med Assoc J 2003;5:260-263.
    • (2003) Isr Med Assoc J , vol.5 , pp. 260-263
    • Nesher, R.1    Ticho, U.2
  • 4
    • 42149182915 scopus 로고    scopus 로고
    • The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents
    • Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des 2008;14:649-654.
    • (2008) Curr Pharm Des , vol.14 , pp. 649-654
    • Mincione, F.1    Scozzafava, A.2    Supuran, C.T.3
  • 5
    • 0035292268 scopus 로고    scopus 로고
    • Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs
    • Gelatt KN, MacKay EO. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Vet Ophthalmol 2001;4:61-67.
    • (2001) Vet Ophthalmol , vol.4 , pp. 61-67
    • Gelatt, K.N.1    MacKay, E.O.2
  • 6
    • 0034981371 scopus 로고    scopus 로고
    • Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs
    • Cawrse MA, Ward DA, Hendrix DV. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res 2001;62:859-863.
    • (2001) Am J Vet Res , vol.62 , pp. 859-863
    • Cawrse, M.A.1    Ward, D.A.2    Hendrix, D.V.3
  • 7
    • 0042205440 scopus 로고    scopus 로고
    • Topical dorzolamide and metabolic acidosis in a neonate
    • Morris S, Geh V, Nischal KK, et al. Topical dorzolamide and metabolic acidosis in a neonate. Br J Ophthalmol 2003;87:1052-1053.
    • (2003) Br J Ophthalmol , vol.87 , pp. 1052-1053
    • Morris, S.1    Geh, V.2    Nischal, K.K.3
  • 8
    • 0035659025 scopus 로고    scopus 로고
    • Contact dermatitis to topical drugs for glaucoma
    • Holdiness MR. Contact dermatitis to topical drugs for glaucoma. Am J Contact Dermat 2001;12:217-219.
    • (2001) Am J Contact Dermat , vol.12 , pp. 217-219
    • Holdiness, M.R.1
  • 9
    • 0032169810 scopus 로고    scopus 로고
    • Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary openangle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group
    • Silver LH. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary openangle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Am J Ophthalmol 1998;126:400-408.
    • (1998) Am J Ophthalmol , vol.126 , pp. 400-408
    • Silver, L.H.1
  • 10
    • 0029121112 scopus 로고
    • A topical carbonic anhydrase inhibitor for glaucoma
    • A topical carbonic anhydrase inhibitor for glaucoma. Med Lett Drugs Ther 1995;37:76-77.
    • (1995) Med Lett Drugs Ther , vol.37 , pp. 76-77
  • 11
    • 0033825972 scopus 로고    scopus 로고
    • Marginal keratitis: An uncommon form of topical dorzolamide allergy
    • Taguri AH, Khan MA, Sanders R. Marginal keratitis: an uncommon form of topical dorzolamide allergy. Am J Ophthalmol 2000;130:120-122.
    • (2000) Am J Ophthalmol , vol.130 , pp. 120-122
    • Taguri, A.H.1    Khan, M.A.2    Sanders, R.3
  • 12
    • 33846554716 scopus 로고    scopus 로고
    • Drug-induced ectropion: What is best practice?
    • Hegde V, Robinson R, Dean F, et al. Drug-induced ectropion: what is best practice? Ophthalmology 2007;114:362-366.
    • (2007) Ophthalmology , vol.114 , pp. 362-366
    • Hegde, V.1    Robinson, R.2    Dean, F.3
  • 13
    • 0033119461 scopus 로고    scopus 로고
    • Irreversible corneal decompensation in patients treated with topical dorzolamide
    • Konowal A, Morrison JC, Brown SV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol 1999;127:403-406.
    • (1999) Am J Ophthalmol , vol.127 , pp. 403-406
    • Konowal, A.1    Morrison, J.C.2    Brown, S.V.3
  • 14
    • 38549144643 scopus 로고    scopus 로고
    • Erythema multiforme after use of topical dorzolamide
    • Munshi V, Ahluwalia H. Erythema multiforme after use of topical dorzolamide. J Ocul Pharmacol Ther 2008;24:91-93.
    • (2008) J Ocul Pharmacol Ther , vol.24 , pp. 91-93
    • Munshi, V.1    Ahluwalia, H.2
  • 15
    • 0035043766 scopus 로고    scopus 로고
    • Dorzolamide-induced immune thrombocytopenia: A case report and literature review
    • Martin XD, Danese M. Dorzolamide-induced immune thrombocytopenia: a case report and literature review. J Glaucoma 2001;10:133-135.
    • (2001) J Glaucoma , vol.10 , pp. 133-135
    • Martin, X.D.1    Danese, M.2
  • 16
    • 78049434564 scopus 로고    scopus 로고
    • Skin eruption and thrombocytopaenia in a woman with glaucoma: A case report
    • Santos VM, Castro RA, Lima CC, et al. Skin eruption and thrombocytopaenia in a woman with glaucoma: a case report. West Indian Med J 2010;59:102-105.
    • (2010) West Indian Med J , vol.59 , pp. 102-105
    • Santos, V.M.1    Castro, R.A.2    Lima, C.C.3
  • 17
    • 2342548698 scopus 로고    scopus 로고
    • Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops
    • Mullins RJ, Lones R, Dutta B. Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops. Australas J Dermatol 2004;45:151-152.
    • (2004) Australas J Dermatol , vol.45 , pp. 151-152
    • Mullins, R.J.1    Lones, R.2    Dutta, B.3
  • 18
    • 39049151289 scopus 로고    scopus 로고
    • Systemic contact dermatitis to dorzolamide eye drops
    • Kluger N, Guillot B, Raison-Peyron N. Systemic contact dermatitis to dorzolamide eye drops. Contact Dermat 2008;58:167-168.
    • (2008) Contact Dermat , vol.58 , pp. 167-168
    • Kluger, N.1    Guillot, B.2    Raison-Peyron, N.3
  • 19
    • 0346732913 scopus 로고    scopus 로고
    • Thygeson's superficial punctate keratitis: Ten years' experience
    • Nagra PK, Rapuano CJ, Cohen EJ, et al. Thygeson's superficial punctate keratitis: ten years' experience. Ophthalmology 2004;111:34-37.
    • (2004) Ophthalmology , vol.111 , pp. 34-37
    • Nagra, P.K.1    Rapuano, C.J.2    Cohen, E.J.3
  • 20
    • 0032901259 scopus 로고    scopus 로고
    • Classification of herpes simplex virus keratitis
    • Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea 1999;18:144-154.
    • (1999) Cornea , vol.18 , pp. 144-154
    • Holland, E.J.1    Schwartz, G.S.2
  • 21
    • 84886840259 scopus 로고    scopus 로고
    • Preservative toxicity in glaucoma medication: Clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
    • Rosin LM, Bell NP. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol 2013;7:2131-2135.
    • (2013) Clin Ophthalmol , vol.7 , pp. 2131-2135
    • Rosin, L.M.1    Bell, N.P.2
  • 22
    • 67650899102 scopus 로고    scopus 로고
    • Outbreak of ocular disease associated with naturally-acquired canine herpesvirus-1 infection in a closed domestic dog colony
    • Ledbetter EC, Kim SG, Dubovi EJ. Outbreak of ocular disease associated with naturally-acquired canine herpesvirus-1 infection in a closed domestic dog colony. Vet Ophthalmol 2009;12:242-247.
    • (2009) Vet Ophthalmol , vol.12 , pp. 242-247
    • Ledbetter, E.C.1    Kim, S.G.2    Dubovi, E.J.3
  • 23
    • 14944366026 scopus 로고    scopus 로고
    • Efficacy of topical nerve growth factor treatment in dogs affected by dry eye
    • Coassin M, Lambiase A, Costa N, et al. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch Clin Exp Ophthalmol 2005;243:151-155.
    • (2005) Graefes Arch Clin Exp Ophthalmol , vol.243 , pp. 151-155
    • Coassin, M.1    Lambiase, A.2    Costa, N.3
  • 25
    • 78549255878 scopus 로고    scopus 로고
    • Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT) in patients with elevated intraocular pressure in a randomized clinical trial
    • Shedden A, Adamsons IA, Getson AJ, et al. Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT) in patients with elevated intraocular pressure in a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 2010;248:1757-1764.
    • (2010) Graefes Arch Clin Exp Ophthalmol , vol.248 , pp. 1757-1764
    • Shedden, A.1    Adamsons, I.A.2    Getson, A.J.3
  • 26
    • 79955016801 scopus 로고    scopus 로고
    • Ocular surface disease in patients with ocular hypertension and glaucoma
    • Stewart WC, Stewart JA, Nelson LA. Ocular surface disease in patients with ocular hypertension and glaucoma. Curr Eye Res 2011;36:391-398.
    • (2011) Curr Eye Res , vol.36 , pp. 391-398
    • Stewart, W.C.1    Stewart, J.A.2    Nelson, L.A.3
  • 27
    • 0344305392 scopus 로고    scopus 로고
    • Ocular factors relevant to antiglaucomatous eyedrop-related keratoepitheliopathy
    • Inoue K, Okugawa K, Kato S, et al. Ocular factors relevant to antiglaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma 2003;12:480-485.
    • (2003) J Glaucoma , vol.12 , pp. 480-485
    • Inoue, K.1    Okugawa, K.2    Kato, S.3
  • 28
    • 84856111207 scopus 로고    scopus 로고
    • A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatographytandem mass spectrometry
    • Kahook MY, Fechtner RD, Katz LJ, et al. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatographytandem mass spectrometry. Curr Eye Res 2012;37:101-108.
    • (2012) Curr Eye Res , vol.37 , pp. 101-108
    • Kahook, M.Y.1    Fechtner, R.D.2    Katz, L.J.3
  • 29
    • 0027207867 scopus 로고
    • Double-blind controlled study of methazolamide in the treatment of essential tremor
    • Busenbark K, Pahwa R, Hubble J, et al. Double-blind controlled study of methazolamide in the treatment of essential tremor. Neurology 1993;43:1045-1047.
    • (1993) Neurology , vol.43 , pp. 1045-1047
    • Busenbark, K.1    Pahwa, R.2    Hubble, J.3
  • 30
    • 0034056033 scopus 로고    scopus 로고
    • Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: Results from two multicenter comfort studies. Brinzolamide Comfort Study Group
    • Silver LH. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group. Surv Ophthalmol 2000;44(Suppl 2):S141-S145.
    • (2000) Surv Ophthalmol , vol.44 , pp. S141-S145
    • Silver, L.H.1
  • 31
    • 80054058311 scopus 로고    scopus 로고
    • From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: A 6-month, multicenter, open-label tolerability switch study
    • Rossi GC, Pasinetti GM, Sandolo F, et al. From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch study. Expert Opin Pharmacother 2011;12:2425-2431.
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 2425-2431
    • Rossi, G.C.1    Pasinetti, G.M.2    Sandolo, F.3
  • 32
    • 0036895588 scopus 로고    scopus 로고
    • The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern."
    • Fung MA. The clinical and histopathologic spectrum of "dermal hypersensitivity reactions," a nonspecific histologic diagnosis that is not very useful in clinical practice, and the concept of a "dermal hypersensitivity reaction pattern." J Am Acad Dermatol 2002;47:898-907.
    • (2002) J Am Acad Dermatol , vol.47 , pp. 898-907
    • Fung, M.A.1
  • 33
    • 84876584468 scopus 로고    scopus 로고
    • Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients
    • Rossi GC, Pasinetti GM, Scudeller L, et al. Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients. Eur J Ophthalmol 2013;23:296-302.
    • (2013) Eur J Ophthalmol , vol.23 , pp. 296-302
    • Rossi, G.C.1    Pasinetti, G.M.2    Scudeller, L.3
  • 34
    • 79953183017 scopus 로고    scopus 로고
    • Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue
    • Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging 2011;28:267-282.
    • (2011) Drugs Aging , vol.28 , pp. 267-282
    • Servat, J.J.1    Bernardino, C.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.